- Home
- AVD vs TELO Comparison
AVD vs TELO Comparison
Compare AVD & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- TELO
- Stock Information
- Founded
- AVD 1969
- TELO 2021
- Country
- AVD United States
- TELO United States
- Employees
- AVD N/A
- TELO N/A
- Industry
- AVD Agricultural Chemicals
- TELO
- Sector
- AVD Industrials
- TELO
- Exchange
- AVD Nasdaq
- TELO NYSE
- Market Cap
- AVD 149.7M
- TELO 124.1M
- IPO Year
- AVD N/A
- TELO 2024
- Fundamental
- Price
- AVD $5.90
- TELO $4.24
- Analyst Decision
- AVD Strong Buy
- TELO
- Analyst Count
- AVD 3
- TELO 0
- Target Price
- AVD $16.67
- TELO N/A
- AVG Volume (30 Days)
- AVD 400.8K
- TELO 88.1K
- Earning Date
- AVD 11-11-2024
- TELO 11-12-2024
- Dividend Yield
- AVD 2.03%
- TELO N/A
- EPS Growth
- AVD N/A
- TELO N/A
- EPS
- AVD N/A
- TELO N/A
- Revenue
- AVD $553,839,000.00
- TELO N/A
- Revenue This Year
- AVD N/A
- TELO N/A
- Revenue Next Year
- AVD $4.69
- TELO N/A
- P/E Ratio
- AVD N/A
- TELO N/A
- Revenue Growth
- AVD N/A
- TELO N/A
- 52 Week Low
- AVD $4.95
- TELO $3.11
- 52 Week High
- AVD $14.28
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- AVD 53.03
- TELO 47.97
- Support Level
- AVD $5.82
- TELO $3.20
- Resistance Level
- AVD $6.61
- TELO $4.95
- Average True Range (ATR)
- AVD 0.37
- TELO 0.50
- MACD
- AVD 0.03
- TELO 0.07
- Stochastic Oscillator
- AVD 44.29
- TELO 59.54
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.